Maria I. Carlo

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

41h-index7.5kcitations260works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(139), Cancer Genomics and Diagnostics(98), Renal and related cancers(90), Cancer Immunotherapy and Biomarkers(36), Genetic factors in colorectal cancer(32)

Publications258 total

High frequency and unique subtypes of meningioma in patients with BAP1 tumor predisposition syndrome
Journal of Neuro-Oncology·2026Open Access
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases
JCO Precision Oncology·2026Open Access
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma
Open Collections·2026Open Access
Subclinical Telomere Biology Disorder in Cancer Patients Heterozygous for the <scp> <i>RTEL1</i> R1264H </scp> Founder Variant
American Journal of Medical Genetics Part A·2025Open Access
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
UNC Libraries·2025Open Access
Supplemental Table 1, Supplemental Table 2, Supplemental Table 3, Supplemental Table 6, Supplemental Table 7, Supplemental Figure 1, and Supplemental Figure 2 from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Data from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Supplemental Materials and Methods from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Supplemental Table 5 from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Supplemental Table 4 from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
CA A Cancer Journal for Clinicians·2025Open Access
High Frequency and Unique Subtypes of Meningioma in Patients with BAP1 Tumor Predisposition Syndrome
2025Open Access
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma
Cancers·2025Open Access
Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2025Open Access
Supplementary Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2025Open Access
Supplementary Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2025Open Access
Spectrum, molecular features, and clinical outcomes of hematologic malignancies and clonal hematopoiesis in li fraumeni syndrome
Blood·2025Open Access
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma
European Urology·2025
Hemoadsorption contribution in neonatal cardiac surgery
Frontiers in Cardiovascular Medicine·2025Open Access
Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell Carcinoma
European Urology·2025· 2 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Robert J. Motzer(22), Martin H. Voss(19), Kenneth Offit(18), Zsofia K. Stadler(18), A. Ari Hakimi(18), Michael F. Walsh(16), Diana Mandelker(15), Ying‐Bei Chen(15), Darren R. Feldman(15), Yelena Kemel(14), Mark E. Robson(14), Chung‐Han Lee(13), Jonathan Coleman(12), Joseph Vijai(11), Karen A. Cadoo(11), Sujata Patil(11), Ozge Ceyhan‐Birsoy(11), Marc Ladanyi(10), Paul Russo(10), Ahmet Zehir(9)